Aripiprazole 1 mg/mL Oral Suspension
This may be suitable for patients who cannot take the solid oral dosage forms or tolerate the ingredients in the commercially available oral solution.
Guiding Novel Neurologic Drug Approvals
The FDA’s review of drug and biological products in this medication class is critical, as a brain impairment impacts between 6.5% and 7.9% of adults in the United States.
Brain Changes Signal Nascent Alzheimer’s
Scientists from the University of Eastern Finland have identified alterations occurring in the human brain that signal the early stages of this common neurogenerative disease.
Copyright © 2000 - 2026 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.